News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta
Mydecine Innovations Group
Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
Core One Labs Inc.
Novamind to Present at Benzinga Conference
Novamind Inc.
Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.
Lobe Sciences
New Edmonton Biotech Startup PsiloTec Health Solutions Targets Projected $100 billion (US) Market for Psychedelic Drugs
Psilotec Health Solutions
Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study
Entheon Biomedical
Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors
MINDCURE
PsyBio Completes Reverse Take-Over Transaction
PsyBio Therapeutics
Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World's First 'MDMA in Alcohol Use Disorder' Clinical Trial
Awakn Life Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.